Marc Hébert

Marc Hébert


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2014 in Biological Psychiatry
Verified
Journal Article
Closed access
JLJoëlle Lavoie
Joëlle Lavoie
PIPlacido Illiano
Placido Illiano
TSTatyana D. Sotnikova
Tatyana D. Sotnikova
Raul R GainetdinovRaul R Gainetdinov
Raul R Gainetdinov
Jean Martin BeaulieuJean Martin Beaulieu
Jean Martin Beaulieu
MHMarc Hébert
Marc Hébert

1 February 2020 in Biological Psychiatry
Verified
Journal Article
Closed access
MHMarc Hébert
Marc Hébert
CMChantal Mérette
Chantal Mérette
AGAnne-Marie Gagné
Anne-Marie Gagné
TPThomas Paccalet
Thomas Paccalet
IMIsabel Moreau
Isabel Moreau
MMMichel Maziade
Michel Maziade

8 December 2021 in Buildings
Verified
Journal Article
Open access
PDF file
Mojtaba ParsaeeMojtaba Parsaee
Mojtaba Parsaee
CDClaude M. H. Demers
Claude M. H. Demers
APAndré Potvin
André Potvin
MHMarc Hébert
Marc Hébert
JLJean-François Lalonde
Jean-François Lalonde
This paper presents a computational method for spatial visualization and probability evaluations of window view access in architecture based on human eyes’ vision fields and biophilic recommendations. Window view access establishes occupants’ visual connections to outdoors. Window view access has not, yet, been discussed in terms of the typical vision fields and related visual experiences. Occupants’ views of outdoors could change from almost blocked and poor to good, wide, and immersive visions in relation to the binocular focus to monocular (far-) peripheral sights of human eyes. The proposed methodological framework includes spatial visualizations and cumulative distribution functions of window view access based on visual experiences of occupants. The framework is integrated with biophilic recommendations and existing rating systems for view evaluations. As a pilot study, the method is used to evaluate occupants’ view access in a space designed with 15 different configurations of windows and overhangs. Results characterize likelihood of experiencing various field of views (FOVs) in case studies. In particular, window-to-wall-area ratios of between 40% and 70% offer optimum distributions of view access in space by offering 75% likelihoods of experiencing good to wide views and less than 25% probabilities of exposing to poor and almost blocked views. Results show the contribution of the proposed method to informative decision-making processes in architecture.

7 June 2023 in Progress in Neuro-Psychopharmacology and Biological Psychiatry
Verified
Journal Article
Closed access
MDMarc-André Dubois
Marc-André Dubois
CPCharles-Antoine Pelletier
Charles-Antoine Pelletier
CMChantal Mérette
Chantal Mérette
VJValérie Jomphe
Valérie Jomphe
RTRose Turgeon
Rose Turgeon
MHMarc Hébert
Marc Hébert

15 May 2024 in Frontiers in Public Health
Verified
Journal Article
Open access
PDF file
VGValérie Gagné
Valérie Gagné
RTRose Turgeon
Rose Turgeon
VJValérie Jomphe
Valérie Jomphe
CDClaude M. H. Demers
Claude M. H. Demers
MHMarc Hébert
Marc Hébert
Introduction: Light’s non-visual effects on the biological clock, cognitive performance, alertness, and mental health are getting more recognized. These are primarily driven by blue light, which triggers specific retinal cells containing melanopsin. Traditionally, research on light has relied on correlated color temperature (CCT) as a metric of its biological influence, given that bluer light corresponds to higher Kelvin values. However, CCT proves to be an inadequate proxy of light’s biological effects. A more precise metric is melanopic Equivalent Daylight Illuminance (mel-EDI), which aligns with melanopsin spectrum. Studies have reported positive cognitive impacts of blue-enriched white light. It’s unclear if the mixed results are due to different mel-EDI levels since this factor wasn’t assessed.Method: Given recent recommendations from experts to aim for at least 250 mel-EDI exposure daily for cognitive benefits, our aim was to assess if a 50-minute exposure to LED light with 250 mel-EDI could enhance concentration and alertness, without affecting visual performance or comfort compared to conventional lighting producing around 150 mel-EDI. To ensure mel-EDI’s impact, photopic lux levels were kept constant across conditions. Conditions were counterbalanced, parameters included subjective sleepiness (KSS; Karolinska Sleepiness Scale), concentration (d2-R test), visual performance (FrACT; Freiburg Visual Acuity and Contrast Test), general appreciation (VAS; Visual Analogous Scale), preferences and comfort (modified OLS; Office Lighting Survey).Results: The experimental light significantly reduced sleepiness (p = 0.03, Cohen’s d = 0.42) and also decreased contrast sensitivity (p = 0.01, Cohen’s d = 0.50). The conventional light was found to be more comfortable (p = 0.002, Cohen’s d = 0.62), cheerful (p = 0.02, Cohen’s d = 0.46) and pleasant (p = 0.005, Cohen’s d = 0.55) while the experimental light was perceived as brighter (p = 0.004, Cohen’s d = 0.58) and tended to be more stimulating (p = 0.10). Notably, there was a preference for conventional lighting (p = 0.004, Cohen’s d=0.56) and concentration was equally improved in both conditions.Discussion: Despite the lack of further improvement in concentration from exposure to blue-enriched light, given the observed benefits in terms of vigilance, further research over an extended period would be justified. These findings could subsequently motivate cognitive optimization through lighting for workers that would benefit from artificial lighting such as in northern regions.

14 March 2025 in Neurobiology of Disease
Verified
Journal Article
Open access
VLVictoria Soto Linan
Victoria Soto Linan
VRVéronique Rioux
Véronique Rioux
MPModesto Peralta
Modesto Peralta
NDNicolas Dupre
Nicolas Dupre
MHMarc Hébert
Marc Hébert
MLMartin Lévesque
Martin Lévesque
Parkinson's disease is typically diagnosed after substantial neurodegeneration despite early non-motor symptoms manifesting decades earlier. These changes offer a promising avenue for diagnostic exploration, especially within the eye, which has been proposed as a "window to the brain." The aim was to identify biomarkers by validating the use of electroretinography, a non-invasive technique, to detect early retinal function anomalies reflecting central dysfunction. Homozygous M83 transgenic mice (n = 10 males, 11 females), overexpressing human A53T α-synuclein, underwent behavioral tests and electroretinography measurements. Histological evaluation was performed at four months to analyze synucleinopathies and neurodegeneration. Electroretinography was also conducted with idiopathic PD patients (mean age 63.35 ± 7.73; disease duration 4.15 ± 2.06; H&Y score 2.07 ± 0.59; n = 12 males, 8 females) and healthy age-matched controls (mean age 61.65 ± 8.39; n = 9 males, 11 females). Rodent electroretinography revealed reduced photopic b-wave, PhNR b-wave, and PhNR-wave amplitudes at two and four months, particularly in females, indicating bipolar and retinal ganglion cell impairment. Based on retinal histological assessment, these changes might arise from α-synuclein pathology occurring in outer retinal layers. Likewise, the scotopic b-wave and PhNR waveform were similarly impaired in female participants with Parkinson's disease. The scotopic oscillatory potentials isolated further identified an attenuated amacrine cell output in females. Findings from both mice and human cohorts indicate that retinal functional impairments can be detected early in the progression of Parkinson's disease, particularly among females. These tools show promise in facilitating early diagnosis, disease monitoring, therapeutic intervention, and ultimately enhancing patient outcomes.